ELI LILLY TO REVISIT ITS DRUG SCRAP BIN

Eli Lilly and Co.'s molecular cast-offs could get a second chance for a productive life under a partnership with a Maryland company. Gene Logic said Thursday it will rescrutinize an untold number of failed, stalled or deprioritized drug candidates from Lilly's labs to look for unseen medical value.

Indianapolis Star (http://www.indystar.com/apps/pbcs.dll/article?AID=/20061013/BUSINESS/610130424/1003)